从饱腹感到物质使用:GLP-1信号在食欲与奖赏中的神经机制
综述阐述中枢GLP-1系统通过脑干、下丘脑、边缘及中脑边缘核团的GLP-1受体整合稳态与享乐性神经环路。GLP-1作为状态依赖性行为终止信号抑制食欲、促进饱腹感并降低奖赏动机价值。GLP-1R激动剂可部分透过血脑屏障经室周器官及邻近核团抑制摄食与药物寻求行为,临床前与临床证据支持其治疗肥胖及可能扩展至物质使用障碍。
要点
- GLP-1是状态依赖性行为终止信号,抑制食欲并降低奖赏动机价值。
- GLP-1R激动剂经室周器官及邻近核团多突触 relay 抑制摄食与药物寻求。
- 临床前与临床证据支持GLP-1R激动剂治疗肥胖,并可能扩展至物质使用障碍。
核心结论
- 中枢GLP-1系统整合稳态与享乐性环路,作为状态依赖性行为终止信号抑制食欲并降低奖赏动机价值。
- GLP-1R激动剂可部分透过血脑屏障经室周器官及邻近核团抑制摄食与药物寻求行为。
- 临床前与临床证据支持GLP-1R激动剂治疗肥胖,新兴证据提示可能扩展至物质使用障碍等奖赏相关适应不良行为。
研究设计与样本
- 综述类文章,检索范围未在摘要中报告。
主要发现
- 脑干GLP-1神经元广泛投射至含GLP-1R的脑干、下丘脑、边缘及中脑边缘核团。
- GLP-1R在代谢与奖赏核团的多样表达使该系统整合动机行为与生理状态。
- GLP-1抑制食欲、促进饱腹感并降低超越可口食物的享乐与动机奖赏价值效应。
- GLP-1R激动剂经室周器官及邻近核团的多突触 relay 抑制摄食与药物寻求行为。
关键数值与推荐
- 无指南推荐条款;摘要未报告具体数值、阈值或剂量。
临床怎么用
- GLP-1R激动剂已用于肥胖及其他代谢紊乱的治疗。
- 对奖赏相关适应不良行为(包括物质使用障碍)的潜在治疗应用值得关注。
局限性
- 摘要未报告检索范围、样本量或具体效应值,无法评估证据强度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The central glucagon-like peptide-1 (GLP-1) system encompasses homeostatic and hedonic neural circuits. GLP-1-producing neurons within the brainstem project broadly to GLP-1 receptor (GLP-1R)-containing brainstem, hypothalamic, limbic, and mesolimbic nuclei. The diverse expression of the GLP-1R throughout metabolic and reward nuclei positions this system to integrate motivated behavior with physiological state. GLP-1 acts as a state-dependent behavior-ending signal that suppresses appetite, promotes satiety, and dampens hedonic and motivational reward value-effects that extend beyond palatable foods. GLP-1R agonists, which can partially cross the blood-brain barrier, engage central GLP-1Rs via circumventricular organs and adjacent nuclei leading to polysynaptic relays that suppress feeding and drug-seeking behaviors. An abundance of preclinical and clinical evidence highlights the efficacy of GLP-1R agonists for the treatment of obesity and other metabolic disorders. Emerging evidence also indicates that the therapeutic application may extend to other disorders characterized by reward-related maladaptive behaviors, including substance use disorders.
引用
- Baumer-Harrison C, Graham MR, De Jonghe BC, et al. From Satiety to Substance Use: Neural Mechanisms of Glucagon-Like Peptide-1 Signaling in Appetite and Reward. Biol Psychiatry. 2026. PMID: 42349741. doi:10.1016/j.biopsych.2026.06.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。